Ischaemia-induced up-regulation of Toll-like receptor 2 in circulating monocytes in cardiogenic shock. 2012

Simina Selejan, and Janine Pöss, and Felix Walter, and Matthias Hohl, and Ralf Kaiser, and Andrey Kazakov, and Michael Böhm, and Andreas Link
Klinik für Innere Medizin III, Universitätsklinikum des Saarlandes, D-66421 Homburg/Saar, Germany.

OBJECTIVE To investigate the role of Toll-like receptor 2 (TLR2) in uncomplicated acute myocardial infarction (AMI) and in cardiogenic shock (CS). RESULTS In patients with uncomplicated AMI (n = 20), CS (n = 30) and in age-matched healthy controls (HC; n = 20), TLR2 expression on monocytes was assessed by flow cytometry. Tumour necrosis factor alpha (TNFα) and interleukin-6 (IL6) expression in monocytes was analysed by intracellular cytokine staining. TLR2 expression was increased in patients with AMI compared with HC [mean fluorescence intensity (MFI) 111.1 ± 8.2 vs. 66.9 ± 1.5, P < 0.001]. In patients with CS, TLR2 expression was further increased (132.8 ± 5.6 MFI, P = 0.009 vs. AMI). This was accompanied by an increased expression of the proinflammatory cytokines TNFα (4.3 ± 1.6% in AMI vs. 20.5 ± 5.9% in CS, P = 0.004) and IL6 (6.3 ± 1.6% in AMI vs. 20.6 ± 6.2% in CS, P = 0.032). Furthermore, in all patients with myocardial infarction (AMI + CS; n = 50), a strong correlation between the monocytic TLR2 expression and the symptom to reperfusion time (r(2)= 0.706, P < 0.001) was found, implying tissue hypoxia dependency. Symptom to reperfusion time is a main factor to influence TLR2 expression but not the presence of CS. TLR2 expression of mononuclear cells exposed in vitro to hypoxia was assessed by flow cytometry and western blot. In vitro measurements showed a hypoxia-mediated monocytic TLR2 expression up-regulation. CONCLUSIONS We demonstrate TLR2 up-regulation and increased proinflammatory cytokine expression in circulating monocytes in AMI/CS depending on disease severity, implying an important role of TLR2 expression in ischaemic injury.

UI MeSH Term Description Entries
D007963 Leukocytes, Mononuclear Mature LYMPHOCYTES and MONOCYTES transported by the blood to the body's extravascular space. They are morphologically distinguishable from mature granulocytic leukocytes by their large, non-lobed nuclei and lack of coarse, heavily stained cytoplasmic granules. Mononuclear Leukocyte,Mononuclear Leukocytes,PBMC Peripheral Blood Mononuclear Cells,Peripheral Blood Human Mononuclear Cells,Peripheral Blood Mononuclear Cell,Peripheral Blood Mononuclear Cells,Leukocyte, Mononuclear
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009203 Myocardial Infarction NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION). Cardiovascular Stroke,Heart Attack,Myocardial Infarct,Cardiovascular Strokes,Heart Attacks,Infarct, Myocardial,Infarction, Myocardial,Infarctions, Myocardial,Infarcts, Myocardial,Myocardial Infarctions,Myocardial Infarcts,Stroke, Cardiovascular,Strokes, Cardiovascular
D011498 Protein Precursors Precursors, Protein
D002116 Calcitonin A peptide hormone that lowers calcium concentration in the blood. In humans, it is released by thyroid cells and acts to decrease the formation and absorptive activity of osteoclasts. Its role in regulating plasma calcium is much greater in children and in certain diseases than in normal adults. Thyrocalcitonin,Calcitonin(1-32),Calcitrin,Ciba 47175-BA,Eel Calcitonin,Calcitonin, Eel,Ciba 47175 BA,Ciba 47175BA
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

Simina Selejan, and Janine Pöss, and Felix Walter, and Matthias Hohl, and Ralf Kaiser, and Andrey Kazakov, and Michael Böhm, and Andreas Link
April 2005, Immunology,
Simina Selejan, and Janine Pöss, and Felix Walter, and Matthias Hohl, and Ralf Kaiser, and Andrey Kazakov, and Michael Böhm, and Andreas Link
June 2002, Journal of immunology (Baltimore, Md. : 1950),
Simina Selejan, and Janine Pöss, and Felix Walter, and Matthias Hohl, and Ralf Kaiser, and Andrey Kazakov, and Michael Böhm, and Andreas Link
January 2018, Frontiers in immunology,
Simina Selejan, and Janine Pöss, and Felix Walter, and Matthias Hohl, and Ralf Kaiser, and Andrey Kazakov, and Michael Böhm, and Andreas Link
November 2015, Anticancer research,
Simina Selejan, and Janine Pöss, and Felix Walter, and Matthias Hohl, and Ralf Kaiser, and Andrey Kazakov, and Michael Böhm, and Andreas Link
September 2006, Critical care medicine,
Simina Selejan, and Janine Pöss, and Felix Walter, and Matthias Hohl, and Ralf Kaiser, and Andrey Kazakov, and Michael Böhm, and Andreas Link
April 2017, Cytometry. Part A : the journal of the International Society for Analytical Cytology,
Simina Selejan, and Janine Pöss, and Felix Walter, and Matthias Hohl, and Ralf Kaiser, and Andrey Kazakov, and Michael Böhm, and Andreas Link
July 2009, Bone,
Simina Selejan, and Janine Pöss, and Felix Walter, and Matthias Hohl, and Ralf Kaiser, and Andrey Kazakov, and Michael Böhm, and Andreas Link
April 2013, Digestive diseases and sciences,
Simina Selejan, and Janine Pöss, and Felix Walter, and Matthias Hohl, and Ralf Kaiser, and Andrey Kazakov, and Michael Böhm, and Andreas Link
April 2008, Critical care medicine,
Simina Selejan, and Janine Pöss, and Felix Walter, and Matthias Hohl, and Ralf Kaiser, and Andrey Kazakov, and Michael Böhm, and Andreas Link
January 2005, Journal of atherosclerosis and thrombosis,
Copied contents to your clipboard!